The Peptide Supply.

The research they don't want simplified

Deep research. Regulatory intelligence. Protocol analysis. No simplification. No compromise.

Latest Research
Ipamorelin: The Cleanest Growth Hormone Peptide in the Research Literature

Ipamorelin: The Cleanest Growth Hormone Peptide in the Research Literature

Ipamorelin: The Cleanest Growth Hormone Peptide in the Research Literature The history of growth hormone secretagogues is a history of tradeoffs. GHRP-6 worked, but it made you ravenously hungry and elevated cortisol. GHRP-2 was more potent, but the cortisol and prolactin stimulation made it difficult to use cleanly. Hexarelin was

Apr 09, 2026 · 6 min read min read
TB-500: The Systemic Repair Peptide

TB-500: The Systemic Repair Peptide

TB-500: The Systemic Repair Peptide Most peptides are local workers. You inject them near a damaged tendon, they get to work on that tendon. The effects are real but geographically constrained. TB-500 behaves differently. Researchers and self-experimenters consistently describe effects at sites distant from the injection point — a shoulder injury

Apr 09, 2026 · 6 min read min read
Epithalon: The Peptide That Wants to Turn Back Your Clock

Epithalon: The Peptide That Wants to Turn Back Your Clock

Epithalon: The Peptide That Wants to Turn Back Your Clock In 1984, a Soviet researcher named Vladimir Khavinson extracted a substance from the pineal glands of cattle and injected it into aging rats. The rats lived longer. Significantly longer. He spent the next four decades trying to understand why. What

Apr 09, 2026 · 5 min read min read
BPC-157: The Peptide That Refuses to Be Ignored

BPC-157: The Peptide That Refuses to Be Ignored

BPC-157: The Peptide That Refuses to Be Ignored There's a compound that's been sitting in the research literature for thirty years, studied almost exclusively by one lab in Zagreb, Croatia — and yet it has quietly become the most widely used experimental peptide on the planet. Athletes

Apr 09, 2026 · 6 min read min read
The FDA & Compounding Pharmacies: What's Actually Happening

The FDA & Compounding Pharmacies: What's Actually Happening

The FDA Came for Peptides. Here's Exactly What Happened. In early 2023, practitioners who had been prescribing compounded BPC-157, TB-500, and ipamorelin to patients started getting calls from their pharmacies. The compounds were being pulled. The supply chain that had quietly served the functional medicine and longevity space

Apr 09, 2026 · 6 min read min read
Weekly Intelligence

Stay at the signal layer

Regulatory shifts, new clinical data, sourcing intelligence, and protocol updates. One email per week.